SCHOTT Pharma Glass Tubing

SCHOTT Tubing Info Letter: facts & figures about global pharma packaging business

Sign up now and receive our Information Letter by email.

Be informed about latest news of global pharma packaging business:

India’s share of biosimilars may reach $ 2 billion by 2015
India forges ahead in the market for biosimilars which includes insulin for diabetes patients. Due to affordability issues, the local market has been growing slowly, explained K V Subramaniam, President and CEO of Reliance Life Sciences, India. However, economic growth and increasing income levels now put India into a key position among the emerging nations by 2015. read full article

India produces 60 percent of the global health vaccines
According to Steven H Myint,chairman of Chennai-based Green Signal Bio Pharma, the Indian vaccine market has become one of the leading vaccine manufacturers. With forecasted revenues of $ 800 million, 70 percent of vaccines are being exported. Global and domestic companies providing affordable, high quality vaccines, play a significant role on the Indian market.read full article

India is entering the era of bioeconomy
Having reached a size of $ 3.5 billion in 2010, the biotechnology sector in India is poised for robust growth. Despite the lack of venture funding, delays in import-export as well as in regulation, insiders predict a 20 percent growth per annum – mainly driven by the growing demand for biopharmaceuticals,biosimilars and vaccines.. read full article

Syringe market to reach $ 11.8 billion by 2017
According to a new report by Global Industry Analysts, Inc. GIA, the market for disposable and reusable syringes is on the rise. Main reasons are an aging population requiring intensive healthcare and a rising number of drugs that need to be administered using syringes. Thereby, the market is witnessing a trend towards pre-filled and needle-less syringes which offer higher safety. read full article

Growth opportunities for the time when drugs go off-patent
The value of drugs going off-patent between 2016 and 2020 will fall 62 percent from the value in the preceding five-year period. Indian off-patent drug exporters will need other ideas to expand business.The Economic Times suggests four key growth drivers: Generic Biologics, new drugs, differentiated or specialty formulations and vaccines. read full article

Bestselling vaccines 2020
Vaccines that, if approved, could put an end to some of today’s most challenging diseases could end up as blockbusters a decade from now. Kalorama Information’s report has identified ten emerging vaccines that could account for $ 24.7 billion in new sales by 2020. Among these are vaccines against Alzheimer’s, AIDS, Hepatitis C and E and Hypertension. read full article